Valneva SE (VALN)
Makes vaccines for diseases like Japanese encephalitis, cholera, and chikungunya.
$5.06+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-29.9%
The outlook
VALN is trading near its 52-week lows and below both its 50- and 200-day averages, signaling weak near-term momentum. Analyst price targets average roughly double the current price, though coverage leans bearish overall. The stock sits at the lower end of its annual range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +141% vs current price
Analyst price target
~12-month · 4 analysts$12.20average target+141.1% vs now
Now $5.06
Low $4.80High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$516.7M
52-wk high
$12.25
52-wk low
$4.75
50-day avg
$5.41
200-day avg
$7.89
Trailing P/E
—